DNA methylation age of blood predicts all-cause mortality in later life.
Marioni RE., Shah S., McRae AF., Chen BH., Colicino E., Harris SE., Gibson J., Henders AK., Redmond P., Cox SR., Pattie A., Corley J., Murphy L., Martin NG., Montgomery GW., Feinberg AP., Fallin MD., Multhaup ML., Jaffe AE., Joehanes R., Schwartz J., Just AC., Lunetta KL., Murabito JM., Starr JM., Horvath S., Baccarelli AA., Levy D., Visscher PM., Wray NR., Deary IJ.
BackgroundDNA methylation levels change with age. Recent studies have identified biomarkers of chronological age based on DNA methylation levels. It is not yet known whether DNA methylation age captures aspects of biological age.ResultsHere we test whether differences between people's chronological ages and estimated ages, DNA methylation age, predict all-cause mortality in later life. The difference between DNA methylation age and chronological age (Δage) was calculated in four longitudinal cohorts of older people. Meta-analysis of proportional hazards models from the four cohorts was used to determine the association between Δage and mortality. A 5-year higher Δage is associated with a 21% higher mortality risk, adjusting for age and sex. After further adjustments for childhood IQ, education, social class, hypertension, diabetes, cardiovascular disease, and APOE e4 status, there is a 16% increased mortality risk for those with a 5-year higher Δage. A pedigree-based heritability analysis of Δage was conducted in a separate cohort. The heritability of Δage was 0.43.ConclusionsDNA methylation-derived measures of accelerated aging are heritable traits that predict mortality independently of health status, lifestyle factors, and known genetic factors.